Mumbai (Maharashtra) [India], August 30: Amanta Healthcare Limited, (“Amanta”, “the Company”) engaged in the development, manufacturing, and marketing of sterile liquid products, including both large and small volume parenterals, secured ₹37.80 crore through its anchor book process on August 29, 2025. According to the exchange filing 06 investors participated in the anchor book offering. The List of Anchorinvestors include:
- Bandhan Small Cap Fund
- Sanshi Fund-1
- Perpetuity Health to Wealth (H2W) Rising Fund
- Aarth Growth Fund
- Sunrise Investment Trust- Sunrise Investment Opportunities Fund
- Finavenue Capital Trust- Finavenue Growth Fund
Amanta Healthcare Limited has allocated a total of 30,00,000Equity Shares to these anchor investors, with each share priced at ₹ 126.
Beeline Capital Advisors Private Limited is the Book Running Lead Manager to the Issue, while MUFG Intime India Private Limited is Registrar to the Issue.
If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.
Divya Agarwal
